Velano Vascular, a San Francisco, CA-based developer of human-centered vascular access technologies, secured $17m in financing.
Backers included a publicly traded healthcare company and a global supplier, which joined existing investors First Round Capital, Griffin Hospital, Kapor Capital, Safeguard Scientifics, Sutter Health, The Children’s Hospital of Philadelphia, White Owl Capital, and a number of health-industry veterans.
The company intends to use the funds to scale and commercialize its family of vascular access technologies.
Led by CEO Eric M. Stone, Velano Vascular is advancing the PIVO™ needle-free device that seeks to improve the overall blood draw experience for patients and practitioners. PIVO is a single-use, disposable device that enables high quality blood samples via indwelling peripheral IV lines, supporting hospitals’ reduced reliance on repeat needle sticks and central line access for blood collection.